Mr. Song holds a bachelor degree in law from the China University of Political Science and Law and an MBA from the China Europe International Business School. He is now an executive chairman of the China Association for the Promotion of Pharmaceutical Innovation and deputy executive director of the National Center for Pharmaceutical Policy and Industrial Development at China Pharmaceutical University (CPU). Prior to his post at CPU, Ruilin was deputy director-general of the Department of Science, Education, Culture, Health and Legal Affairs of the Legislative Affairs Office of the State Council. In 2008, he participated in the establishment of the Medical Policy Research Center of the Chinese Medical Association. In the same year, Ruilin also served as the deputy leader of the Drug Policy Research Group of the “The Strategic Plan of Chinese Health in 2020”. He is also the member of the Capital Health Policy Advisory Committee of Experts and the Beijing Medical Reform Committee of Experts.